Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUPPRESS: Atazanavir/Ritonavir vs Darunavir/Ritonavir in Second-Line HIV Treatment
NCT01605084Phase 3Withdrawn
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Planned start Jun 2012; status: withdrawn.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01605084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01605084.